1. Search Result
Search Result
Results for "

CENPs

" in MedChemExpress (MCE) Product Catalog:

11

Inhibitors & Agonists

1

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-10299
    GSK-923295
    35+ Cited Publications

    Kinesin Apoptosis Cancer
    GSK-923295 is a special, allosteric inhibitor of centromere-associated protein-E (CENP-E) kinesin motor ATPase activity, with Ki of 3.2±0.2 nM and 1.6± 0.1 nM for human and canine, respectively.
    GSK-923295
  • HY-19530

    Kinesin Cancer
    PF-2771 is a potent and selective centromere protein E (CENP-E) inhibitor, inhibiting CENP-E motor activity with an IC50 of 16.1 nM; PF-2771 is used as an anticancer agent.
    PF-2771
  • HY-121569

    Kinesin Cancer
    Syntelin is a selective centromere protein E (CENP-E) inhibitor with IC50 at 160 nM. Syntelin has antitumor activity .
    Syntelin
  • HY-RS02490

    Small Interfering RNA (siRNA) Others

    CENPS Human Pre-designed siRNA Set A contains three designed siRNAs for CENPS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    CENPS Human Pre-designed siRNA Set A
    CENPS Human Pre-designed siRNA Set A
  • HY-150265

    TMP-NVOC linker-Halo

    Kinesin Others
    TNH (TMP-NVOC linker-Halo) is a dimeric protein chemical inducer that can enter living cells and recruit proteins to cellular structures. TNH senses light signals and acts by recruiting proteins to kinetochores and releasing them from kinetochores (depending on CENP-E (kinesin-7)) .
    TNH
  • HY-161898

    Kinesin Cancer
    CENP-E-IN-3 (compound 4) is a potent CENP-E inhibitor. CENP-E-IN-3 has the potential for the research of cancer .
    CENP-E-IN-3
  • HY-161897

    Kinesin Cancer
    CENP-E-IN-2 (compound 3) is a photoswitchable CENP-E inhibitor, with the pIC50 of 6.82 without light illumination and 5.85 with 365 nm light illumination. CENP-E-IN-2 has antitumor activity .
    CENP-E-IN-2
  • HY-163288

    Histone Methyltransferase HSP Apoptosis Cancer
    EZH2/HSP90-IN-29 is a dual inhibitor for EZH2 and HSP90, with IC50s of 6.29 nM and 60.1 nM, for EZH2 and HSP90, respectively. EZH2/HSP90-IN-29 increases apoptosis/necrosis-related gene expression, induces cell cycle arrest at M phase and inhibits reactive oxygen species (ROS) catabolism pathway. EZH2/HSP90-IN-29 is able to cross the blood-brain-barrier (BBB) .
    EZH2/HSP90-IN-29
  • HY-110090

    Microtubule/Tubulin Kinesin Apoptosis Cancer
    UA62784 is a microtubule polymerization inhibitor that interacts with tubulin dimers. UA62784 is a novel specific inhibitor of centromere protein E (CENP-E) kinesin. UA62784 can be used for the study of pancreatic cancer .
    UA62784
  • HY-177876

    Kinesin Others
    Cenpemlin is a CENP-M inhibitor that disrupts the CENP-M/CENP-L interaction. Cenpemlin can be used for investigating centromere-kinetochore interactions and dynamic kinetochore assembly during cell division .
    Cenpemlin
  • HY-183225

    Drug Intermediate Inflammation/Immunology
    Heparin disaccharide IV-A sodium is an immune-modulatory heparin disaccharide sodium salt that can be attached to biodegradable polymeric particles to form carbohydrate-enhanced nanoparticles (CENPs) .
    Heparin disaccharide IV-A sodium

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: